Skip to main content
Log in

Characterization of four basic models of indirect pharmacodynamic responses

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

Four basic models of indirect pharmacodynamic responses were characterized in terms of changing dose, Imax or Smax, and IC50 or SC50 to examine the effects of these fundamental drug properties on response profiles. Standard pharmacokinetic parameters were used for generating plasma concentration, and response-time profiles using computer simulations. Comparisons to theoretical expectations were made. In all four models, the maximum response (Rmax) (inhibition or stimulation) and the time of its occurrence (TRmax) were dependent on the model, dose, Imax or Smax, and IC50 or SC50 values,. An increase in dose or a decrease in IC50 or SC50 by the same factor produced, as theoretically expected, identical and superimposable pharmacodynamic response patterns in each of the models. Some parameters (TRmax, ABEC) were nearly proportional to log dose, while others (Rmax, CRmax) were nonlinear. Assessment of expected response signature patterns as demonstrated in this report may be helpful in experimental designs and in assigning appropriate models to pharmacodynamic data.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. N. L. Dayneka, V. Garg, and W. J. Jusko. Comparison of four basic models of indirect pharmacodynamic responses.J. Pharmacokin. Biopharm. 21:457–478 (1993).

    Article  CAS  Google Scholar 

  2. R. Nagashima, R. A. O'Reilly, and G. Levy. Kinetics of pharmacologic effects in man: the anticoagulant action of warfarin.Clin. Pharmacol. Ther. 10:22–35 (1969).

    CAS  PubMed  Google Scholar 

  3. W. J. Jusko and H. C. Ko. Physiologic indirect response models characterize diverse types of pharmacodynamic effects.Clin. Pharmacol. Ther. 56:406–419 (1994).

    Article  CAS  PubMed  Google Scholar 

  4. K. H. Lew, E. A. Ludwig, M. A. Milad, K. Donovan, E. Middleton, Jr., J. J. Ferry, and W. J. Jusko. Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics.Clin. Pharmacol. Ther. 54:402–414 (1993).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. M. A. Milad, E. A. Ludwig, S. Ane, E. Middleton, and W. J. Jusko. Pharmacodynamic model for joint exogenous and endogenous corticosteroid suppression of lymphocyte trafficking.J. Pharmacokin. Biopharm. 22:469–480 (1995).

    Article  Google Scholar 

  6. J. C. Dearden. Partitioning and lipophilicity in quantitative structure-activity relationships.Environ. Health Prosp. 61:203–228 (1985).

    Article  CAS  Google Scholar 

  7. W. Krzyzanski and W. J. Jusko. Mathematical formalism for the properties of four basic models of indirect pharmacodynamic responsesJ. Pharmacokin. Biopharm. accepted (1997).

  8. W. Krzyzanski and W. J. Jusko. Integrated functions for four basic models of indirect pharmacodynamic response. Submitted for publication (1996).

  9. J. A. Wald, D. E. Salazar, H. Cheng, and W. J. Jusko. Two-compartment basophil cell trafficking model for methylprednisolone pharmacodynamics.J. Pharmacokin. Biopharm. 19:521–536 (1991).

    Article  CAS  Google Scholar 

  10. H. C. Ko, and W. J. Jusko. Pharmacodynamic modeling of a 5α-reductase inhibitor: Finasteride.Pharmacother. 15:509–511 (1995).

    CAS  Google Scholar 

  11. Z-X. Xu, M. Lee, R. A. Blum, and W. J. Jusko. Pharmacodynamic modeling of prednisolone effects on natural killer cell trafficking.Pharm. Res. 12:459–463 (1995).

    Article  CAS  PubMed  Google Scholar 

  12. W. J. Jusko, H. C. Ko, and W. F. Ebling. Convergence of direct and indirect pharmacodynamic response models.J. Pharmacokin. Biopharm. 23:5–8 (1995).

    Article  CAS  Google Scholar 

  13. A. Rescigno and G. Segre.Drug and Tracer Kinetics. Chapter 4, Blaisdell Publishing Co., New York, 1966.

    Google Scholar 

  14. L. Z. Benet. General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics.J. Pharm. Sci. 61:536–541 (1972).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported in part by Grant No. 24211 from the National Institute of General Medical Sciences, National Institutes of Health.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sharma, A., Jusko, W.J. Characterization of four basic models of indirect pharmacodynamic responses. Journal of Pharmacokinetics and Biopharmaceutics 24, 611–635 (1996). https://doi.org/10.1007/BF02353483

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02353483

Key Words

Navigation